Iridex Q2 2024 GAAP EPS $(0.16) Misses $(0.11) Estimate, Sales $12.631M Miss $12.800M Estimate
Portfolio Pulse from Benzinga Newsdesk
Iridex (NASDAQ:IRIX) reported Q2 2024 GAAP EPS of $(0.16), missing the $(0.11) estimate by 45.45%. Sales were $12.631M, missing the $12.800M estimate by 1.32%. EPS improved by 5.88% YoY, while sales decreased by 1.74% YoY.
August 08, 2024 | 9:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Iridex reported Q2 2024 GAAP EPS of $(0.16), missing the $(0.11) estimate by 45.45%. Sales were $12.631M, missing the $12.800M estimate by 1.32%. EPS improved by 5.88% YoY, while sales decreased by 1.74% YoY.
The significant miss on EPS and slight miss on sales estimates are likely to negatively impact IRIX's stock price in the short term. Despite the YoY improvement in EPS, the overall performance did not meet market expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100